Chengdu Syncor Pharmaceutical Co., Ltd.

This study is testing a new radioactive drug called BPR-6023021 for people with advanced solid tumors that have spread to the bones. The main goals are to find a safe dose and see how well the drug works to control the cancer in the bones. The trial is for adults whose cancer has…

This study tests whether adding BPR-101 capsules to standard antibiotic treatment (metronidazole) can prevent bacterial vaginosis (BV) from returning. About 80 women with BV will receive either the combination or a placebo. The goal is to see if the new approach lowers the chance…